Eddie L. Imada

1.2k citations
21 papers · 378 indexed · h-index 9
Topics
Prostate Cancer Treatment and Research (3 papers)Neurofibromatosis and Schwannoma Cases (3 papers)Acute Myeloid Leukemia Research (2 papers)
Partner nations
United StatesBrazilItaly

In The Last Decade

Eddie L. Imada

19 papers receiving 376 citations

Peers

Eddie L. Imada
Comparison fields: 5 of 77
  • Molecular Biology 163
  • Oncology 78
  • Pulmonary and Respiratory Medicine 76
  • Cancer Research 65
  • Immunology 60
Replace Kejing Yan with:
Kejing Yan China
Petra Adams‐Quack Germany
Huda Asif Pakistan
Rentao Yu China
Na Tian China
Tina Senff Germany
Sanqi An China
Sitharam Ramaswami United States
Kimiyo N. Yamamoto Japan
Mikhail V. Kulak United States
Eddie L. Imada relative to Kejing Yan China Kejing Yan's profile →
Citations per field
00.5×6.9×
Kejing Yan · 1×
Citations per year

Countries citing papers authored by Eddie L. Imada

Since Specialization
Citations

This map shows the geographic impact of Eddie L. Imada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie L. Imada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie L. Imada more than expected).

Fields of papers citing papers by Eddie L. Imada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddie L. Imada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie L. Imada. The network helps show where Eddie L. Imada may publish in the future.

Co-authorship network of co-authors of Eddie L. Imada

This figure shows the co-authorship network connecting the top 25 collaborators of Eddie L. Imada. A scholar is included among the top collaborators of Eddie L. Imada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddie L. Imada. Eddie L. Imada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 5
4 1
5 3
6 2
7 4
8 1
9 3
10 65
11 22
12 114
13 60
14 1
15 7
16 9
17 13
18 14
19 16
20 35

About Eddie L. Imada

Eddie L. Imada is a scholar working on Transplantation, Cancer Research and Modeling and Simulation, having authored 21 papers that have together received 378 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Cancer Research (65 citations), Oncology (78 citations) and Immunology (60 citations). Eddie L. Imada has collaborated with scholars based in United States, Brazil and Italy. Frequent co-authors include Luigi Marchionni, Claudio Zanettini, Mohamed Omar, Elizabeth Colantuoni, Ben Langmead, Giovanni Parmigiani, Elisete Pains Rodrigues, Christopher Wilks, André Luíz Martinez de Oliveira and Brad Solomon. Their work appears in journals such as Nature Communications, Genome biology and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026